Osteopetrosis in young women presented with a fragility fracture and very high bone density
Main Article Content
Abstract
Osteopetrosis is a rare genetic disease characterized by increased bone density due to osteoclast dysfunction, leading to osteosclerosis on radiological findings. Osteopetrosis is broadly divided into autosomal recessive and autosomal dominant forms; the former is more severe with high mortality, while the latter is more common and often presents with fragility fractures in late childhood or adulthood. We report a case of a 29-year-old Burmese woman with right leg pain who was unable to walk or bear weight after minor trauma. She had no history of previous fractures, dental problems, or chronic bone pain. She denied any chronic medical conditions or visual or hearing problems and was not on any medications. Examination showed tenderness of the left thigh with a limited range of motion; otherwise, the findings were unremarkable. Laboratory findings revealed normal serum calcium, phosphate, and parathyroid hormone levels, except for a low vitamin D level. A BMD scan showed high bone density. Genetic testing for skeletal disorders revealed heterogeneous CLCN7 mutations consistent with osteopetrosis. This case highlights the importance of considering osteopetrosis in patients with fragility fractures and high bone density. Early diagnosis and management can help prevent recurrent fractures and improve quality of life.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles in this journal are copyrighted by the Royal Thai Army Medical Department and published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
may be read and used for academic purposes, such as teaching, research, or citation, with proper credit given to the author and the journal.
Use or modification of the articles is prohibited without permission.
Statements expressed in the articles are solely the opinions of the authors.
Authors are fully responsible for the content and accuracy of their articles.
Any other republication of the articles requires permission from the journal.
References
Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009;4(1):5.
Funck-Brentano T, Zillikens MC, Clunie G, Siggelkow H, Appelman-Dijkstra NM, CohenSolal M. Osteopetrosis and related osteoclast disorders in adults: A review and knowledge gaps On behalf of the European calcified tissue society and ERN BOND. Eur J Med Genet. 2024;69:104936.
Penna S, Villa A, Capo V. Autosomal recessive osteopetrosis: mechanisms and treatments. Dis Model Mech. 2021;14(5):dmm048940.
Waguespack SG, Hui SL, DiMeglio LA, Econs MJ. Autosomal Dominant Osteopetrosis: Clinical Severity and Natural History of 94 Subjects with a Chloride Channel 7 Gene Mutation. J Clin Endocrinol Metab. 2007;92(3):771–8.
Reddy MH R. Osteopetrosis (Marble Bone Disease): A Rare Disease in Children. Int J Clin Pediatr Dent. 2011;4(3):232–4.
Henriksen K, Gram J, Høegh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, et al. Osteoclasts from Patients with Autosomal Dominant Osteopetrosis Type I Caused by a T253I Mutation in Low-Density Lipoprotein Receptor-Related Protein 5 Are Normal in Vitro but Have Decreased Resorption Capacity in Vivo. Am J Pathol. 2005;167(5):1341–8.
Wang Z, Li X, Wang Y, Fu W, Liu Y, Zhang Z, Wang C. Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study. Front Endocrinol (Lausanne). 2022;13:819641.
Coudert AE, de Vernejoul MC, Muraca M, Del Fattore A. Osteopetrosis and Its Relevance for the Discovery of New Functions Associated with the Skeleton. Int J Endocrinol. 2015;2015:1–8.
Öğütcen-Toller M, Tek M, Şener İ, Bereket C, İnal S, Özden B. Intractable Bimaxillary Osteomyelitis in Osteopetrosis: Review of the Literature and Current Therapy. Journal of Oral and Maxillofacial Surgery. 2010;68(1):167–75.
Bénichou OD, Laredo JD, de Vernejoul MC. Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone. 2000;26(1):87–93.
Waguespack SG, Hui SL, White KE, Buckwalter KA, Econs MJ. Measurement of TartrateResistant Acid Phosphatase and the Brain Isoenzyme of Creatine Kinase Accurately Diagnoses Type II Autosomal Dominant Osteopetrosis but Does Not Identify Gene Carriers. J Clin Endocrinol Metab. 2002;87(5):2212–7.
Lam D, Sándor G, Holmes H, Carmichael R, Clokie C. Marble bone disease: A review of osteopetrosis and its oral health implications for dentists. J Can Dent Assoc. 2007;73:839–43.
Chailurkit LO, Ongphiphadhanakul B, Aekplakorn W. Update on vitamin D status in sunshine-abundant Thailand, 2019-2020. Nutrition. 2023;116:112161.
Landa J, Margolis N, Di Cesare P. Orthopaedic Management of the Patient With Osteopetrosis. Journal of the American Academy of Orthopaedic Surgeons. 2007 Nov;15(11):654–62.
Hwang JM, Kim IO, Wang KC. Complete Visual Recovery in Osteopetrosis by Early Optic Nerve Decompression. Pediatr Neurosurg. 2000;33(6):328–32.